Showing results (31-40 of 123) with videos related to
Sort By:
Pageof 13
Human Psychopharmacology|June 3, 2017
Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or durationJeffrey Guina, Sayon Roy, Ankur Gupta, et al.Psychopharmacology|October 1, 2011
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependenceDaniel D Langleben, Elliot L Busch, Charles P O'Brien, et al.Biorxiv : the Preprint Server for Biology|September 26, 2025
Long-acting naltrexone restores network connectivity in subjects with co-morbid cannabis and opioid use disorderLindsey M Brier, Daniel D Langleben, Corinde E Wiers, et al.Addiction Biology|May 18, 2026
Long-Acting Naltrexone Restores Network Connectivity in Subjects With Comorbid Cannabis and Opioid Use DisorderLindsey M Brier, Daniel D Langleben, Corinde E Wiers, et al.Radiation Research|September 25, 2004
Biological effects of radiofrequency fields: does modulation matter?Kenneth R Foster, Michael H RepacholiInternational Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 20, 2011
Thermal aspects of exposure to radiofrequency energy: report of a workshopKenneth R Foster, Joseph J MorrisseyBiomedical Engineering Online|March 3, 2004
Modeling thermal responses in human subjects following extended exposure to radiofrequency energyKenneth R Foster, Eleanor R AdairIEEE Pulse|November 21, 2017
Smartphone Apps Meet Evidence-Based Medicine: The Future of Medicine May (Or May Not) Be in Your SmartphoneKenneth R Foster, David J CallansHealth Physics|October 29, 2013
Wi-Fi and health: review of current status of researchKenneth R Foster, John E MoulderHealth Physics|June 27, 2013
Radiofrequency energy exposure from the Trilliant smart meterKenneth R Foster, Richard A TellPageof 13